Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Contrast-Enhanced Spectral Mammography: Potential to Improve Diagnostic Accuracy

NCT03929822 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.

NCT NCT03929822
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03929822 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Contrast-Enhanced Spectral Mammography: Potential to Improve Diagnostic Accuracy
Lead sponsor
Memorial Sloan Kettering Cancer Center
Phase
Observational
Overall status
Terminated
Start date
April 23, 2019
Completion date
January 19, 2023
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast screening